|
Journal of Histochemistry and Cytochemistry, Vol. 49, 539-549, April 2001, Copyright © 2001, The Histochemical Society, Inc.
Comparative Analysis of Galectins in Primary Tumors and Tumor Metastasis in Human Pancreatic Cancer
Pascal O. Berberata,
Helmut Friessa,
Li Wanga,
Zhaowen Zhua,
Thorsten Bleya,
Luciano Frigerib,
Arthur Zimmermannc, and
Markus W. Büchlera
a Department of Visceral and Transplantation Surgery, University of Bern, Inselspital, Bern, Switzerland
b The Scripps Research Institute, La Jolla, California,
c Institute of Pathology, University of Bern, Inselspital, Bern, Switzerland
Correspondence to:
Helmut Friess, Dept. of Visceral and Transplantation Surgery, University of Bern, Inselspital, CH-3010 Bern, Switzerland. E-mail: helmut.friess@insel.ch
Galectins are galactoside-binding proteins that exhibit an important function in tumor progression by promoting cancer cell invasion and metastasis formation. Using Northern blotting and Western blotting analysis, in situ hybridization (ISH), and immunohistochemistry (IHC), we studied galectin-1 and galectin-3 in tissue samples of 33 primary pancreatic cancers and in tumor metastases in comparison to 28 normal pancreases. Furthermore, the molecular findings were correlated with the clinical and histopathological parameters of the patients. Northern blotting and Western blotting analysis showed significantly higher galectin-1 and galectin-3 mRNA and protein levels in pancreatic cancer samples than in normal controls. For galectin-1, no ISH signals and immunoreactivity were observed in acinar or ductal cells in the normal pancreas and in pancreatic cancer cells, whereas fibroblasts and extracellular matrix cells around the cancer mass exhibited strong mRNA signals and immunoreactivity. Galectin-3 mRNA signals and immunoreactivity were strongly present in most pancreatic cancer cells, whereas in the normal controls only faint ISH and IHC signals were seen in some ductal cells. Metastatic pancreatic cancer cells exhibited moderate to strong galectin-3 immunoreactivity but were negative for galectin-1. No relationship between the galectin-1 and galectin-3 mRNA levels and the tumor stage or between the IHC staining score and the tumor stage was found. However, galectin-1 mRNA levels and the IHC staining score were significantly higher in poorly differentiated tumors compared with well/moderately differentiated tumors, whereas for galectin 3 no differences were found. The expression pattern of galectin-1 and galectin-3 in pancreatic cancer tissues indicates that galectin-1 plays a role in the desmoplastic reaction that occurrs around pancreatic cancer cells, whereas galectin-3 appears to be involved in cancer cell proliferation. High levels of galectin-3 in metastatic cancer cells suggest an impact on metastasis formation. (J Histochem Cytochem 49:539549, 2001)
Key Words:
galectins, pancreas, pancreatic carcinoma, metastasis

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Camby, M. Le Mercier, F. Lefranc, and R. Kiss
Galectin-1: a small protein with major functions
Glycobiology,
November 1, 2006;
16(11):
137R - 157R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Masamune, M. Satoh, J. Hirabayashi, K. Kasai, K. Satoh, and T. Shimosegawa
Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells
Am J Physiol Gastrointest Liver Physiol,
April 1, 2006;
290(4):
G729 - G736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zuidervaart, P. J. Hensbergen, M.-C. Wong, A. M. Deelder, C. P. Tensen, M. J. Jager, and N. A. Gruis
Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
Invest. Ophthalmol. Vis. Sci.,
March 1, 2006;
47(3):
786 - 793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fischer, H. Sanchez-Ruderisch, M. Welzel, B. Wiedenmann, T. Sakai, S. Andre, H.-J. Gabius, L. Khachigian, K. M. Detjen, and S. Rosewicz
Galectin-1 Interacts with the {alpha}5{beta}1 Fibronectin Receptor to Restrict Carcinoma Cell Growth via Induction of p21 and p27
J. Biol. Chem.,
November 4, 2005;
280(44):
37266 - 37277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Kim, H.-Y. Sohn, S. Y. Yoon, J.-H. Oh, J. O. Yang, J. H. Kim, K. S. Song, S.-M. Rho, H. S. Yoo, Y. S. Kim, et al.
Identification of Gastric Cancer-Related Genes Using a cDNA Microarray Containing Novel Expressed Sequence Tags Expressed in Gastric Cancer Cells
Clin. Cancer Res.,
January 15, 2005;
11(2):
473 - 482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shen, M. D. Person, J. Zhu, J. L. Abbruzzese, and D. Li
Protein Expression Profiles in Pancreatic Adenocarcinoma Compared with Normal Pancreatic Tissue and Tissue Affected by Pancreatitis as Detected by Two-Dimensional Gel Electrophoresis and Mass Spectrometry
Cancer Res.,
December 15, 2004;
64(24):
9018 - 9026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Elad-Sfadia, R. Haklai, E. Balan, and Y. Kloog
Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity
J. Biol. Chem.,
August 13, 2004;
279(33):
34922 - 34930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Hoyer, M. Pang, D. Gui, I. P. Shintaku, I. Kuwabara, F.-T. Liu, J. W. Said, L. G. Baum, and M. A. Teitell
An Anti-Apoptotic Role for Galectin-3 in Diffuse Large B-Cell Lymphomas
Am. J. Pathol.,
March 1, 2004;
164(3):
893 - 902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Iacobuzio-Donahue, R. Ashfaq, A. Maitra, N. V. Adsay, G. L. Shen-Ong, K. Berg, M. A. Hollingsworth, J. L. Cameron, C. J. Yeo, S. E. Kern, et al.
Highly Expressed Genes in Pancreatic Ductal Adenocarcinomas: A Comprehensive Characterization and Comparison of the Transcription Profiles Obtained from Three Major Technologies
Cancer Res.,
December 15, 2003;
63(24):
8614 - 8622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Martins, S. E. Matsuo, K. N. Ebina, M. A. V. Kulcsar, C. U. M. Friguglietti, and E. T. Kimura
Galectin-3 Messenger Ribonucleic Acid and Protein Are Expressed in Benign Thyroid Tumors
J. Clin. Endocrinol. Metab.,
October 1, 2002;
87(10):
4806 - 4810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shimamura, M. Sakamoto, Y. Ino, K. Shimada, T. Kosuge, Y. Sato, K. Tanaka, H. Sekihara, and S. Hirohashi
Clinicopathological Significance of Galectin-3 Expression in Ductal Adenocarcinoma of the Pancreas
Clin. Cancer Res.,
August 1, 2002;
8(8):
2570 - 2575.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 2001
|
|
|